Brown & Brown organic growth recovers to 1.2% as soft market weighs on results

Brown & Brown reported 1.2% organic revenue growth in Q3, up from a decline in Q2 but below last year's 3.5%. Total revenue rose 7.4% to $1.7B, driven by acquisitions. Net income increased 5.7% to $240M, while EPS slipped 1.5% to $0.67. The company attributed challenges to a soft market and rate environment, with CEO Powell Brown noting efforts to win customers despite these conditions. The Accession acquisition contributed to a 23.4% revenue increase over nine months.

Original reporting
Published Oct 27, 2026, 5:39 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 27, 2026, 8:51 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Brown & Brown organic growth recovers to 1.2% as soft market weighs on results — source image
Decision brief

The 30-second read

$BRONeutralMed
01

Why it matters

The earnings release provides fresh data on revenue composition and profitability, influencing valuation models for the insurer.

02

Market read

First‑time disclosure of Q3 performance with material figures; relevant for traders monitoring insurance sector earnings trends.

03

What to watch

Litigation deduction and delayed new business revenue may be temporary; future quarters could rebound.

Relevance 7/10Novelty 7/10Timing: after-hours

Background

Brown & Brown reported Q3 2026 results, noting a recovery in organic revenue after a prior decline and a sizable share repurchase program.

Company-level read

Ticker impact

$BRONeutralHigh confidence
Context

Q3 earnings release shows organic revenue growth of 1.2% and a 5.7% rise in net income, marking the first public disclosure of the quarter's results.

Expected impact

likely modest downside as investors weigh slower organic growth against strong buyback and dividend payout.

Evidence & confidence

The earnings numbers are new and material; however, the slowdown in organic revenue suggests revenue quality concerns, while the $750M share repurchase provides support.

Market effects

Highlights pressure on mid-sized insurance brokers from softening catastrophe pricing, potentially affecting peers.

U.S. insurance sector may see modest re‑rating as organic growth slows across the industry.

Limited to insurance and brokerage segments; no broader macro impact.

Counterpoint

Buyback and dividend strength could outweigh organic growth concerns, supporting a bullish stance.

Key entities

  • Brown & Brown Inc.

    U.S. insurance brokerage firm reporting Q3 earnings.

Related articles

$BROHighAI 8/10

Why Brown & Brown Stock Slumped by 5% Today

Brown & Brown (BRO) stock fell 5% after Q3 earnings missed estimates. Revenue rose 7% YoY to $1.73B, below the $1.76B consensus. GAAP net income increased 6% to $240M, while adjusted EPS grew 2% to $1.07, missing the $1.09 estimate. The company cited a challenging rate environment and attributed some growth to its Accession acquisition, but organic revenue grew only 1% YoY to $1.46B.

$BROMed

Brown & Brown Inc (BRO) (Q3 2026) Earnings Call Highlights: Revenue Up 7.4%

Brown & Brown Inc (BRO) reported Q3 2026 revenue up 7.4% to $1.07B, but adjusted EBITDAC margin fell 200 bps to 34.6%. Specialty Distribution organic revenue declined 0.8%, missing expectations due to competition and pricing pressures. The company anticipates further declines in Q4 and faces ongoing litigation impacts. Integration costs for Accession have increased to $250-300M.

$BROMed

What Brown & Brown (BRO) Said on Its Q3 Earnings Call

Brown & Brown (BRO) reported Q3 earnings, noting market shifts in California and Texas, and pricing pressures in commercial earthquake business. The company expects 2027 growth of 2%-4% for retail and 1%-3% for specialty distribution. Accession acquisition raised synergy targets to $50M for 2026 and $175M by 2028. AI initiatives are expanding across the company, with tools like Claude and COMPASS being deployed. The board increased the dividend by 9%.

$BROHighAI 8/10

Brown & Brown (BRO) Q3 2026 Earnings Call Transcript

Brown & Brown (BRO) reported Q3 2026 revenues of $1.7B, up 7.4% YoY. Organic revenue grew 1.2%, while adjusted EBITDAC margin fell 200 bps to 34.6%. Adjusted EPS rose 2% to $1.07. The company raised its dividend by 9%, marking 33 consecutive years of increases. Retail segment outperformed expectations, while specialty distribution faced headwinds. The company repurchased $750M in shares YTD, including $250M in Q3.

$BROMed

Truist cuts Brown & Brown stock price target to $85 on lower estimates

Truist Securities reduced its price target for Brown & Brown (NYSE:BRO) to $85 from $90, citing lower 2026 and 2027 EPS estimates. The firm maintained a Buy rating, basing the target on a 14x multiple of its 2027 EBITDA estimate. BRO's Q3 earnings missed expectations, with revenue at $1.72B and EPS at $1.07, though both showed year-over-year growth. The company's organic growth slowed, and its adjusted EBITDAC margin declined by 200 basis points.